Magnitude and Impacts of Adverse Events of Injectable Containing Shorter Regimen in Programmatic Management of Multi-Drug Resistant Tuberculosis in Ethiopia: A Retrospective Cohort Study

BACKGROUND: Since its launch as a standardized treatment for multidrug-resistant tuberculosis (MDR-TB) in Ethiopia in April 2018, the safety profile of the shorter injectable regimen under a programmatic setting has not been well studied. Thus, this study aimed to assess the status of adverse events...

Descripción completa

Detalles Bibliográficos
Autores principales: Achalu, Daniel Legese, Mohammed, Foziya Getachew, Teferi, Mekonnen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644888/
https://www.ncbi.nlm.nih.gov/pubmed/38023629
http://dx.doi.org/10.2147/TCRM.S423163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644888/
https://www.ncbi.nlm.nih.gov/pubmed/38023629
http://dx.doi.org/10.2147/TCRM.S423163

Ejemplares similares